Efficacy and tolerability of agomelatine in generalized anxiety disorder (gad): A randomised double-blind, placebo-controlled trial with escitalopram as validator

Authors
Category Primary study
ConferenceInternational Journal of Neuropsychopharmacology
Year 2012
This article has no abstract
Epistemonikos ID: 42c235b48a84dbb65f1c45bb9e1901ba8ea284cf
First added on: Apr 30, 2026